U.S. Companies Dominate Many Sectors. Should They Be In Your Portfolio Too?

Oct 08, 2022

As the largest economy in the world, the United States is an economic powerhouse.

It attracts the attention and capital of investors across the globe. It’s not just because the U.S. is a large market of almost 330 million consumers with a high standard of living. The U.S. is home to some of the largest and most successful companies in the world, many of them with a global presence. In fact, in many sectors American firms dominate and investors looking to buy into those sectors will find it impossible to ignore these U.S.-based companies.


How big is big?

The U.S. capital markets are the deepest and most liquid in the world. That liquidity, meaning that shares can be bought and sold freely, provides investors with more choices of stocks and securities across many sectors than anywhere else. American markets also feature a regulatory framework supporting transparency and investor protection.


Just how big are they? The New York Stock Exchange (NYSE) is the largest in the world and accounts for roughly 40% of the world’s stock market capitalization. In second place is U.S.-based NASDAQ, home to some of the largest technology companies on the planet. The U.S. corporate bond market is also the world’s largest.


Sector dominance

This market heft is demonstrated in the dominance of many key sectors by U.S. companies, including sectors in demand by investors (see table this page based on the S&P Global Broad Market Index1). Consider these:


Technology. The dominance of U.S. firms in tech is well known. In 2019, seven out of 10 of the largest technology companies in the world were American.2 As the table shows, this pre-eminence is especially strong in software, with 86% of the sector in the index being U.S. owned.


Health Care. Over $7.8 trillion (USD) a year is spent on health care globally. Nearly half of that total – $3.5 trillion – is spent in the United States.3 It’s no surprise, then, that American firms hold sway in this sector too, with an especially strong presence in the Health Care Provider and Biotech areas.

 

Consumer Segments. With its large, affluent market and powerful brands, the United States is home to some heavy hitters providing products and services to the consumer market. U.S. companies making household products dominate their sector, and American specialty retailers hold supremacy in their space.


It’s easy to see why investors are so attracted to American investments, whether it’s for the steady performance of consumer staples or the high growth potential of technology or biotech. With their global dominance, many U.S. firms also provide global exposure for a portfolio, as they may operate or generate revenue in hundreds of countries.


Easy access

For Canadians, the most common way to access the U.S. market is through mutual funds or exchange-traded funds (ETFs). It will be obvious if you own a U.S. or North American equity fund that you have such exposure. However, what this heavy dominance in key sectors suggests is that you’ll likely have even more exposure in other funds as well. Many global funds, depending on their mandate, will likely include a high number of U.S. companies. Specialty funds that concentrate on technology, health care or financial services will also have a big American presence.


Chances are these global leaders are already working for you in your portfolio. If you’d like to understand more about your access to these sectors or the role they play in your portfolio, let’s review your investment strategy soon.


1 World Economic Forum with data from S&P. https://www.weforum.org/agenda/2020/02/dominance-american-companies-global-markets-industry/
2 Forbes Global 2000 List, Investopedia, November 2019. https://www.investopedia.com/articles/markets/030816/worlds-top-10-technology-companies-aapl-googl.asp
3 Investing in Health Care Stocks, April 2020. https://www.fool.com/investing/stock-market/market-sectors/healthcare/

Insurance products and services are offered by life insurance licensed advisors through Chevron Wealth Preservation Inc., a wholly owned subsidiary of Echelon Wealth Partners Inc. This material is provided for general information and is not to be construed as an offer or solicitation for the sale or purchase of life insurance products or securities mentioned herein. Every effort has been made to compile this material from reliable sources however no warranty can be made as to its accuracy or completeness. Before acting on any of the above, please seek individual financial advice based on your personal circumstances. Please note that only Echelon Wealth Partners is a member of CIPF and regulated by IIROC; Chevron Wealth Preservation is not.

 

Forward-looking statements are based on current expectations, estimates, forecasts and projections based on beliefs and assumptions made by author. These statements involve risks and uncertainties and are not guarantees of future performance or results and no assurance can be given that these estimates and expectations will prove to have been correct, and actual outcomes and results may differ materially from what is expressed, implied or projected in such forward-looking statements.

 

The opinions expressed in this report are the opinions of the author and readers should not assume they reflect the opinions or recommendations of Echelon Wealth Partners Inc. or its affiliates. Assumptions, opinions and estimates constitute the author’s judgment as of the date of this material and are subject to change without notice. We do not warrant the completeness or accuracy of this material, and it should not be relied upon as such. Before acting on any recommendation, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. Past performance is not indicative of future results. These estimates and expectations involve risks and uncertainties and are not guarantees of future performance or results and no assurance can be given that these estimates and expectations will prove to have been correct, and actual outcomes and results may differ materially from what is expressed, implied or projected in such forward-looking statements. Echelon Wealth Partners Inc. is a member of the Investment Industry Regulatory Organization of Canada and the Canadian Investor Protection Fund.

Share This Post

13 May, 2024
The normal narrative for encouraging investors to look at emerging markets typically goes like this: The valuations are cheap, the demographics/rising incomes are supportive of growth, and they offer diversification. Perhaps this is more the marketing narrative. Kind of how, like for infrastructure strategies, they always talk about how many bridges need repairing. We are not refuting any of the above reasons, as they have been rather perennial for many, many years. And yet, for those who know us, we have been rather negative or at least cool on emerging markets for a long time. How long? Well, this negative view persisted for well over a decade. This is us giving ourselves a pat on the back since Emerging Markets (EM) have done roughly nothing for the past 12 years as Developed Markets (DM) have charged higher (chart).
06 May, 2024
Take your pick. There is no shortage of both good and bad news floating about the financial markets. To be fair, this is always the case. The hard part is understanding which side is stronger today and which side will be stronger tomorrow. With markets up low to mid-single digits following a very strong Q4 finish to 2023, most would agree the optimists are carrying the day at the moment. It is not just rose-coloured glasses; there is good news out there. Economic growth signs or momentum appear to be improving year-to-date. Dial back a few quarters, and the U.S. economy remained resilient while other economies softened or were rather lacklustre, including Canada, Europe, Japan, and China, to highlight some of the biggies. Today, while Canada is struggling, momentum in the U.S. has moved even higher, and there are signs of improvement in most jurisdictions.
29 Apr, 2024
There are three things you should rarely ever bet against: the Leaf’s opposing team in the playoffs, the American consumer’s ability to spend, and corporate profits. As we are now about halfway through U.S. earnings season, once again, positive surprises remain the norm; 81% have beaten. It's a bit better than the 20-year average of 75%. The fact is that companies are good at managing analysts’ expectations. At least enough to beat them when the numbers hit the tape. The size of the positive surprises have been encouraging as well, at just under 10%. The highest surprise magnitude in some time. One of our reservations on the sustainability of this market rally over the past couple of quarters has been the flat earnings revisions. In other words, global markets are up over 20% but earnings estimates have remained flat or tilted down slightly. More often than not, markets trend in the same direction as earnings revisions. Earnings get revised up when companies raise guidance and/or analysts become more encouraged about growth prospects. That is a good thing for markets. Obviously, downward revisions are bad. Yet estimates have remained very flat as markets marched higher, a challenging combination.
More Posts
Share by: